Thiagarajan Shivakumar, Sathe Pranav, Bal Munita, Patil Asawari
Division of Head & Neck, Department of Surgical Oncology, Tata Memorial Centre and Homi Bhabha National Institute (HBNI), Mumbai, India.
Lotus Hospital, Mumbai, India.
Indian J Surg Oncol. 2024 Dec;15(4):733-737. doi: 10.1007/s13193-024-01982-2. Epub 2024 Jun 13.
Fine needle aspiration (FNA) is a commonly used investigation for salivary gland lesions. The modified MSRSGC was introduced to standardise the FNA reporting of major salivary gland lesions. A frozen section is also used intraoperatively for these lesions. In this retrospective study, we included all patients who were treated at our institute between January 2012 to December 2019. The FNA reports of all the patients were reclassified based on the modified MSRSGC, and the sensitivity, specificity, and positive and negative predictive values were calculated. We also assessed the indication for utilising the frozen section and correlated it with the preoperative FNA and the final histopathology report. A total of 325 patients satisfied the eligibility criteria and were included in this study. The sensitivity and specificity, positive predictive value, and negative predictive value of the modified MSRSGC were 64.18% and 91.94% and 92.27% and 63.11%, respectively. The frozen section (FS) was done in 131 patients, the commonest reason was for obtaining a primary diagnosis ( = 104,79.3%). When the FNA was type V and above the primary diagnosis was that of malignancy in the vast majority ( < 0.001, kappa 0.563). The values of the modified MSRSGC were comparable with available literature in all categories except categories I and II which were higher than what is reported in the literature. When the preoperative FNA was modified to MSRSGC V and above, the possibility of malignancy was high, and the use of FS for primary diagnosis may not add much value intraoperatively.
细针穿刺抽吸活检(FNA)是唾液腺病变常用的检查方法。改良的MSRSGC被引入以规范主要唾液腺病变的FNA报告。术中也对这些病变使用冰冻切片。在这项回顾性研究中,我们纳入了2012年1月至2019年12月在我院接受治疗的所有患者。所有患者的FNA报告根据改良的MSRSGC重新分类,并计算敏感性、特异性、阳性和阴性预测值。我们还评估了使用冰冻切片的指征,并将其与术前FNA和最终组织病理学报告相关联。共有325例患者符合纳入标准并被纳入本研究。改良的MSRSGC的敏感性和特异性、阳性预测值和阴性预测值分别为64.18%、91.94%、92.27%和63.11%。131例患者进行了冰冻切片(FS),最常见的原因是获得初步诊断(=104,79.3%)。当FNA为V型及以上时,绝大多数情况下初步诊断为恶性(<0.001,kappa 0.563)。除I类和II类高于文献报道外,改良的MSRSGC在所有类别中的值与现有文献相当。当术前FNA修改为MSRSGC V型及以上时,恶性可能性高,术中使用FS进行初步诊断可能不会增加太多价值。